Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)

Market Cap	12.14B
Revenue (ttm)	2.27B
Net Income (ttm)	594.07M
Shares Out	530.17M
EPS (ttm)	1.12
PE Ratio	20.43
Forward PE	n/a
Dividend	0.48 (2.06%)
Ex-Dividend Date	Jul 4, 2024

Volume	875,430
Open	24.31
Previous Close	23.27
Day's Range	23.07 - 24.31
52-Week Range	16.27 - 25.26
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Tibet Cheezheng Tibetan Medicine

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. It provides products in the areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,091
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2023, Tibet Cheezheng Tibetan Medicine's revenue was 2.05 billion, an increase of 0.02% compared to the previous year's 2.04 billion. Earnings were 581.20 million, an increase of 22.99%.